Guido Reber

Author PubWeight™ 18.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Fluvastatin increases the expression of adhesion molecules, monocyte chemoattractant protein-1 and tissue factor in HUVEC stimulated by patient IgG fractions containing antiphospholipid antibodies. Thromb Haemost 2005 1.47
2 Influence of antidepressants on hemostasis. Dialogues Clin Neurosci 2007 1.23
3 Induction of TLR2 expression by inflammatory stimuli is required for endothelial cell responses to lipopeptides. Mol Immunol 2008 0.95
4 NFkappaB is an essential intermediate in the activation of endothelial cells by anti-beta(2)-glycoprotein 1 antibodies. Thromb Haemost 2002 0.94
5 The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. Blood 2006 0.93
6 Evaluation of unfractionated heparin and recombinant hirudin on survival in a sustained ovine endotoxin shock model. Crit Care Med 2002 0.93
7 Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies. Blood 2011 0.90
8 Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease. J Autoimmun 2004 0.88
9 Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction. Eur Heart J 2010 0.85
10 Agreement of a new whole-blood PT/INR test using capillary samples with plasma INR determinations. Thromb Res 2005 0.82
11 Inflammatory and prothrombotic states in obese children of European descent. Obesity (Silver Spring) 2012 0.82
12 A multicenter evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism. Thromb Haemost 2008 0.80
13 Acquired factor XIII deficiency: a therapeutic challenge. Thromb Haemost 2013 0.80
14 Evaluation of the CoaguChek XS Plus system in a Swiss community setting. Thromb Haemost 2009 0.79
15 Anti-beta(2)-glycoprotein I ELISA assay: the influence of different antigen preparations. Thromb Haemost 2009 0.79
16 HPA-genotyping and antiplatelet antibodies in female blood donors. Hematol J 2003 0.79
17 Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome. Clin Sci (Lond) 2008 0.79
18 Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 2004 0.78
19 Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation study. Thromb J 2013 0.77
20 An analysis of experimental conditions influencing the anti-beta2-glycoprotein I ELISA assay results. Ann N Y Acad Sci 2007 0.76
21 Immunization of LDL receptor-deficient mice with beta2-glycoprotein 1 or human serum albumin induces a more inflammatory phenotype in atherosclerotic plaques. Thromb Haemost 2007 0.76
22 Point of care management of heparin administration after heart surgery: A randomized, controlled trial. Intensive Care Med 2006 0.75
23 [Evaluating the biological efficacy of clopidogrel: genotype or phenotype?]. Rev Med Suisse 2010 0.75
24 Discrepancy between capillary and venous International Normalised Ratio (INR) in a patient on vitamin-K antagonist: potentially serious clinical consequences. Thromb Haemost 2006 0.75
25 Felty's syndrome and hypofibrinogenemia: an unusual target for anti-cyclic citrullinated peptide antibodies? Mod Rheumatol 2015 0.75
26 A novel frameshift mutation in FGA (c.1846 del A) leading to congenital afibrinogenemia in a consanguineous Syrian family. Blood Coagul Fibrinolysis 2011 0.75